Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat

EMBO Journal

Volumn 17, Issue 23, 1998, Pages 7056-7065

  Bieniasz, Paul D ^a   Grdina, Therese A ^a   Bogerd, Hal P ^a   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclin; HIV 1; Tat; Transcription

Indexed keywords

CYCLINE; CYSTEINE; TRANSACTIVATOR PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SPECIES DIFFERENCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES;

EID: 0032401752     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.23.7056     Document Type: Article

References (44)

1. Alonso, A., Derse, D. and Peterlin, B.M. (1992) Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol., 66, 4617-4621.
2. Blair, W.S., Fridell, R.A. and Cullen, B.R. (1996) Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. EMBO J., 15, 1658-1665.
3. Blau, J., Xiao, H., McCracken, S., O'Hare, P., Greenblatt, J. and Bentley, D. (1996) Three functional classes of transcriptional activation domains. Mol. Cell. Biol., 16, 2044-2055.
4. Bogerd, H.P., Fridell, R.A., Blair, W.S. and Cullen, B.R. (1993) Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus. J. Virol., 67, 5030-5034.
5. Cujec, T.P., Okamoto, H., Fujinaga, K., Meyer, J., Chamberlin, H., Morgan, D.O. and Peterlin, B.M. (1997) The HIV transactivator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 2645-2657.
6. Cullen, B.R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol., 152, 684-704.
7. Cullen, B.R. (1998) HIV-1 auxiliary proteins: making connections in a dying cell. Cell, 93, 685-692.
8. Dahmus, M. (1996) Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem., 271, 19009-19012.
9. Dingwall, C., Ernberg, I., Gait, M.J., Green, S.M., Heaphy, S., Karn, J., Lowe, A.D., Singh, M. and Skinner, M.A. (1990) HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J., 9, 4145-4153.
10. Feinberg, M.B., Baltimore, D. and Frankel, A.D. (1991) The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl Acad. Sci. USA, 88, 4045-4049.
11. Feng, S. and Holland, E.C. (1988) HIV-1 Tat transactivation requires the loop sequence within TAR. Nature, 334, 165-167.
12. Fields, S. and Song, O.-K. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
13. Fridell, R.A., Harding, L.S., Bogerd, H.P. and Cullen, B.R. (1995) Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology, 209, 347-357.
14. Garcia-Martinez, L.F., Mavankal, G., Neveu, J.M., Lane, W.S., Ivanov, D. and Gaynor, R.B. (1997) Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J., 16, 2836-2850.
15. Gold, M.O., Yang, X., Herrmann, C.H. and Rice, A.P. (1998) PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol., 72, 4448-4453.
16. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 19, 805-816.
17. Herrmann, C.H. and Rice, A.P. (1995) Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol., 69, 1612-1620.
18. Jones, K.A. (1997) Taking a new TAK on Tat transactivation. Genes Dev., 11, 2593-2599.
19. Kao, S.-Y., Calman, A.F., Luciw, P.A. and Peterlin, B.M. (1987) Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature, 330, 489-493.
20. Kashanchi, F., Piras, G., Radonovich, M.F., Duvall, J.F., Fattaey, A., Chiang, C.-M., Roeder, R.G. and Brady, J.N. (1994) Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature, 367, 295-299.
21. Luo, Y., Madore, S.J., Parslow, T.G., Cullen, B.R. and Peterlin, B.M. (1993) Functional analysis of interactions between Tat and the transactivation response element of human immunodeficiency virus type 1 in cells. J. Virol., 67, 5617-5622.
22. Madore, S.J. and Cullen, B.R. (1993) Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol., 67, 3703-3711.
23. Mancebo, H.S.Y. et al. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev., 11, 2633-2644.
24. Marciniak, R.A. and Sharp, P.A. (1991) HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J., 10, 4189-4196.
25. Newstein, M., Stanbridge, E.J., Casey, G. and Shank, P.R. (1990) Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 Tat-mediated transactivation in rodent cells. J. Virol., 64, 4565-4567.
26. Okamoto, H., Sheline, C.T., Corden, J.L., Jones, K.A. and Peterlin, B.M. (1996) Trans-activation by HIV Tat requires the C-terminal domain of RNA polymerase II. Proc. Natl Acad. Sci. USA, 93, 11575-11579.
27. Parada, C.A. and Roeder, R.G. (1996) Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature, 384, 375-378.
28. Peng, J., Zhu, Y., Milton, J.T. and Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev., 12, 755-762.
29. Roy, S., Delling, U., Chen, C.-H., Rosen, C.A. and Sonenberg, N. (1990) A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated transactivation. Genes Dev., 4, 1365-1373.
30. Selby, M.J. and Peterlin, B.M. (1990) Transactivation by HIV-1 Tat via a heterologous RNA binding protein. Cell, 62, 769-776.
31. Sengupta, D.J., Zhang, B., Kraemer, B., Pochart, P., Fields, S. and Wickens, M. (1996) A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl Acad. Sci. USA, 93, 8496-8501.
32. Shibuya, H., Irie, K., Ninomiya-Tsuji, J., Goebl, M., Taniguchi, T. and Matsumoto, K. (1992) New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature, 357, 700-702.
33. Southgate, C. Zapp, M.L. and Green, M.R. (1990) Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature, 345, 640-642.
34. Sune, C., Hayashi, T., Liu, Y., Lane, W.S., Young, R.A. and Garcia-Blanco, M.A. (1997) CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol. Cell. Biol., 17, 6029-6039.
35. Tiley, L.S., Madore, S.J., Malim, M.H. and Cullen, B.R. (1992) The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev., 6, 2077-2087.
36. Vernet, T., Dignard, D. and Thomas D.Y. (1987) A family of yeast expression vectors containing the phage f1 intergenic region. Gene, 52, 225-233.
37. Weeks, K.M., Ampe, C., Schultz, S.C., Steitz, T.A. and Crothers, D.M. (1990) Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science, 249, 1281-1285.
38. Wei, P., Garber, M.E., Fang, S.-M., Fischer, W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
39. Xiao, H., Tao, Y., Greenblatt, J. and Roeder, R.G. (1998) A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc. Natl Acad. Sci. USA, 95, 2146-2151.
40. Yang, X., Herrmann, C.H. and Rice, A.P. (1996) The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol., 70, 4576-4584.
41. Yang, X., Gold, M.O., Tang, D.N., Lewis, D.E., Aguilar-Cordova, E., Rice, A.P. and Herrmann, C.H. (1997) TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl Acad. Sci. USA, 94, 12331-12336.
42. Zhou, Q. and Sharp, P.A. (1996) Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science, 274, 605-610.
43. Zhou, Q., Chen, D., Pierstorff, E. and Luo, K. (1998) Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J., 17, 3681-3691.
44. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B. and Price, D.H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev., 11, 2622-2632.